OPN-101

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameOPN-101
Drug Alias NameOPN-101
ClassificationBiologicsNatural product/Extract
Mechanisms of ActionImmunomodulatorsIL-10 release stimulantsT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOpsona Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOpsona Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A